Trials / Recruiting
RecruitingNCT06620627
Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection
Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection (PROCEED-CRC)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- Natera, Inc. · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Accepted
Summary
The PROCEED-CRC study will prospectively collect blood samples from participants who are at average risk of colorectal cancer (CRC). Samples will be used for research use and the development of a blood-based CRC screening test.
Detailed description
Participants who meet study inclusion criteria will be invited to enroll in the study and will provide written consent prior to study procedures. Participants will provide blood samples and will be required to have a colonoscopy performed within 120 days of their blood draw. No test results from the blood collection will be provided to participants or clinicians.
Conditions
Timeline
- Start date
- 2024-01-26
- Primary completion
- 2025-07-31
- Completion
- 2025-10-31
- First posted
- 2024-10-01
- Last updated
- 2025-01-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06620627. Inclusion in this directory is not an endorsement.